Trade Summary

Yesterday, Levy Raphi, serving as Chief Financial Officer at Alpha Tau Medical Ltd. (DRTS), sold 20,000 shares at $12.00 per share, for a total transaction value of $240,044.00. Following this transaction, Levy Raphi now holds 90,180 shares of DRTS.

This sale represents a 18.15% decrease in Levy Raphi's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 30, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 8:21 AM ET, 1 day after the trade was made.